Ainscow Robert 4
4 · ASP Isotopes Inc. · Filed Apr 13, 2026
Research Summary
AI-generated summary of this filing
ASP Isotopes (ASPI) COO Robert Ainscow Sells 25,000 Shares
What Happened Robert Ainscow, Chief Operating Officer of ASP Isotopes Inc. (ASPI), sold 25,000 shares on March 6, 2026. The reported weighted-average price was $4.51 per share, for total proceeds of approximately $112,775. The filing shows these sales were effected under a pre-established Rule 10b5-1 trading plan.
Key Details
- Transaction date: 2026-03-06 (reported on Form 4 filed 2026-04-13).
- Amount sold: 25,000 shares; weighted-average price reported $4.51; individual sale prices ranged $4.42–$4.58 per share (multiple trades).
- Total proceeds: about $112,775.
- Footnote: Sales were made pursuant to a Rule 10b5-1 plan adopted December 13, 2024. The filer offers to provide the breakdown of shares sold at each separate price on request.
- Ownership after transaction: Not specified in the provided filing.
- Timeliness: The Form 4 was filed more than a month after the trades (filed Apr 13 for Mar 6 trades), so the report was late relative to the usual two-business-day reporting window.
Context This was an open-market sale under a 10b5-1 plan. Such pre-arranged plans allow insiders to sell on a schedule and are commonly used for routine liquidity; they do not on their own indicate the insider’s current view of the company.
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
[F1][F2]2026-03-06$4.51/sh−25,000$112,775→ 1,512,817 total
Footnotes (2)
- [F1]Represents sales effected pursuant to a Rule 10b5-1 trading plan adopted by the filing person on December 13, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.42 to $4.58, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.
Signature
/s/ Donald Ainscow, as attorney-in-fact|2026-04-13